» Articles » PMID: 20435945

The Influence of Perioperative Coagulation Status on Postoperative Blood Loss in Complex Cardiac Surgery: a Prospective Observational Study

Overview
Journal Anesth Analg
Specialty Anesthesiology
Date 2010 May 4
PMID 20435945
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Coagulopathy leading to excessive blood loss is a serious complication of cardiac surgery. In this prospective cohort study, we measured patients' coagulation status before and after cardiopulmonary bypass (CPB) and examined their relationships with postoperative blood loss.

Methods: Patients undergoing complex cardiac surgery with CPB who did not have preexisting coagulopathy were eligible. Detailed clinical and coagulation data were prospectively collected on all patients. Coagulation testing was performed before and after CPB, and included measures of thrombin generation, clotting factor consumption and dilution, clot stabilization, and fibrinolysis. The associations of variables with post-CPB blood loss (estimated loss from CPB to intensive care unit admission and 24-hour chest tube drainage) were assessed with the Spearman rank correlation test and multivariable linear regression.

Results: The median blood loss among the 101 study patients was 952 mL (interquartile range, 601-1553 mL). Variables independently associated with increasing blood loss were as follows: previous sternotomies (P = 0.01), lower pre-CPB prothrombin fragment F1 + 2 levels (measure of thrombin generation; P = 0.001), lower post-CPB platelet counts (P = 0.01), larger percent decrease in fibrinogen levels (P = 0.05), and higher post-CPB soluble fibrin monomer levels (measure of thrombin activity and clot stabilization; P < 0.0001) (model R(2) = 0.43).

Conclusions: In complex cardiac surgery, blood loss is directly influenced by reduced pre-CPB thrombin generation rate, increased post-CPB consumption and dilution of clotting factors, as well as inadequate post-CPB clot stabilization. This information can aid in identifying patients at high risk for excessive blood loss and testing new interventions aimed at reducing the burden of this complication. The validity and generalizability of these findings need to be assessed by other studies.

Citing Articles

A clinical comparison of the effects of six disposable cardiopulmonary bypass circuits on bleeding and coagulation: a quality assurance project.

Takhar S, Martinez-Perez S, Beairsto B, Derman R, Serrick C, Otalora-Esteban M Can J Anaesth. 2025; 72(2):319-333.

PMID: 39966202 DOI: 10.1007/s12630-024-02903-1.


Association between cardiopulmonary bypass duration and early major adverse cardiovascular events after surgical repair of supravalvular aortic stenosis.

Zhang S, Wei C, Peng B, Lv L, Pei F, Xia J Front Cardiovasc Med. 2025; 12:1519251.

PMID: 39906758 PMC: 11790573. DOI: 10.3389/fcvm.2025.1519251.


Population pharmacokinetic model of tranexamic acid in patients who undergo cardiac surgery with cardiopulmonary bypass.

Nakai T, Tamura T, Miyagawa Y, Inagaki T, Mutsuga M, Yamada S Eur J Clin Pharmacol. 2025; 81(3):441-449.

PMID: 39820511 PMC: 11825552. DOI: 10.1007/s00228-025-03802-0.


Modern Treatment of Valvulopathies in Patients with Congenital Hemophilia.

Badescu M, Badulescu O, Gheorghe L, Butnariu L, Ouatu A, Popescu D Life (Basel). 2024; 14(3).

PMID: 38541679 PMC: 10971620. DOI: 10.3390/life14030354.


Cardiovascular Safety of Celecoxib after Cardiac Surgery with Cardiopulmonary Bypass: A Retrospective Cohort Study.

Nahara I, Takeuchi M, Tanaka S, Yonekura H, Takeda C, Kawakami K Ann Clin Epidemiol. 2024; 3(4):101-108.

PMID: 38505473 PMC: 10760469. DOI: 10.37737/ace.3.4_101.